CY1105777T1 - Σχηματισμος και ανιοντο-ανταλλαγη των εσωτepικων κρυσταλλικων αλατων αμμωνιου εχινοκανδινης β - Google Patents

Σχηματισμος και ανιοντο-ανταλλαγη των εσωτepικων κρυσταλλικων αλατων αμμωνιου εχινοκανδινης β

Info

Publication number
CY1105777T1
CY1105777T1 CY20061101646T CY061101646T CY1105777T1 CY 1105777 T1 CY1105777 T1 CY 1105777T1 CY 20061101646 T CY20061101646 T CY 20061101646T CY 061101646 T CY061101646 T CY 061101646T CY 1105777 T1 CY1105777 T1 CY 1105777T1
Authority
CY
Cyprus
Prior art keywords
echinocandin
salt
intercrystally
antion
exchange
Prior art date
Application number
CY20061101646T
Other languages
Greek (el)
English (en)
Inventor
Brian Weston Dalder
Michael Anthony Dotlich
Neil John Kallman
Samuel Dean Larsen
Sharon Van Den Berghe Snorek
Jeffrey Thomas Vicenzi
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of CY1105777T1 publication Critical patent/CY1105777T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00Nanotechnology
    • Y10S977/84Manufacture, treatment, or detection of nanostructure
    • Y10S977/895Manufacture, treatment, or detection of nanostructure having step or means utilizing chemical property
    • Y10S977/896Chemical synthesis, e.g. chemical bonding or breaking
    • Y10S977/898Enzymatic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CY20061101646T 1999-03-03 2006-11-13 Σχηματισμος και ανιοντο-ανταλλαγη των εσωτepικων κρυσταλλικων αλατων αμμωνιου εχινοκανδινης β CY1105777T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12307399P 1999-03-03 1999-03-03
PCT/US2000/005494 WO2000052036A1 (en) 1999-03-03 2000-03-02 Formation and anion-exchange of crystalline echinocandin ammonium salts

Publications (1)

Publication Number Publication Date
CY1105777T1 true CY1105777T1 (el) 2011-02-02

Family

ID=22406562

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101646T CY1105777T1 (el) 1999-03-03 2006-11-13 Σχηματισμος και ανιοντο-ανταλλαγη των εσωτepικων κρυσταλλικων αλατων αμμωνιου εχινοκανδινης β

Country Status (18)

Country Link
US (1) US6590073B2 (enExample)
EP (1) EP1155034B1 (enExample)
JP (1) JP4063497B2 (enExample)
KR (1) KR20020002476A (enExample)
CN (1) CN1351610A (enExample)
AT (1) ATE338060T1 (enExample)
AU (1) AU767956B2 (enExample)
BR (1) BR0009248A (enExample)
CA (1) CA2362826A1 (enExample)
CY (1) CY1105777T1 (enExample)
DE (1) DE60030415T2 (enExample)
DK (1) DK1155034T3 (enExample)
ES (1) ES2270819T3 (enExample)
HK (1) HK1040087A1 (enExample)
IL (1) IL145186A0 (enExample)
PT (1) PT1155034E (enExample)
WO (1) WO2000052036A1 (enExample)
ZA (1) ZA200107999B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743777B1 (en) * 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
CN1337968A (zh) 1998-12-09 2002-02-27 伊莱利利公司 蓝刺菌素环肽化合物的纯化
DK1155034T3 (da) 1999-03-03 2007-01-08 Lilly Co Eli Dannelse og anionbytning af indre krystallinske echinocandin B-ammoniumsalte
JP2002538097A (ja) 1999-03-03 2002-11-12 イーライ リリー アンド カンパニー 薬学的経口ecb処方物および組成物の作製方法
CN100335122C (zh) * 1999-03-03 2007-09-05 伊莱利利公司 含有成胶束表面活性剂的棘白菌素药物制剂
KR20020003864A (ko) 1999-03-03 2002-01-15 피터 지. 스트링거 에키노칸딘/탄수화물 착물
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
TW200826957A (en) * 2006-10-16 2008-07-01 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Purification processes for echinocandin-type compounds
EP2062909A1 (en) * 2007-11-21 2009-05-27 SOLVAY (Société Anonyme) Peptide production and purification process
US9394340B2 (en) 2009-03-24 2016-07-19 Cadila Healthcare Limited Purification process for lipopeptides
WO2010108637A1 (en) * 2009-03-27 2010-09-30 Axellia Pharmaceuticals Aps Crystalline compound
CN102464704B (zh) * 2010-11-05 2013-12-11 上海医药工业研究院 一种化合物及其制备方法和用途
CN102485879A (zh) * 2010-12-03 2012-06-06 上海医药工业研究院 一种用于生产wf11899a的发酵培养基
CN102295686A (zh) * 2011-09-09 2011-12-28 杭州华东医药集团生物工程研究所有限公司 一种纽莫康定b0的提取纯化方法
CN102659930B (zh) * 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
CN102627688B (zh) * 2012-03-30 2014-12-31 上海天伟生物制药有限公司 一种高纯度环肽化合物及其制备方法和用途
CN102627689B (zh) * 2012-03-30 2014-08-06 上海天伟生物制药有限公司 一种环肽类化合物的水合物及其制备方法和用途
CN105669839B (zh) * 2014-12-05 2019-08-13 重庆乾泰生物医药有限公司 一种棘白菌素b母核或其盐的水合物及制备方法和用途
CN105669840B (zh) * 2014-12-05 2019-06-04 重庆乾泰生物医药有限公司 一种高纯度棘白菌素b母核盐酸盐的晶体及其制备方法
US12060439B2 (en) 2018-10-25 2024-08-13 Napp Pharmaceutical Group Limited Polymorph of echinocandin antifungal agent

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3293482A (en) 1962-06-21 1966-12-20 Rca Corp Plural output traveling wave tube
JPS5134916B2 (enExample) 1974-03-06 1976-09-29
US4299763A (en) 1979-12-13 1981-11-10 Eli Lilly And Company A-30912B Nucleus
US4293489A (en) 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
CA1170598A (en) * 1979-12-13 1984-07-10 Bernard J. Abbott Process for the preparation of cyclic peptide nuclei
US4293482A (en) 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4320052A (en) 1979-12-13 1982-03-16 Eli Lilly And Company Derivatives of A-30912A nucleus
US4293483A (en) 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4304716A (en) 1979-12-13 1981-12-08 Eli Lilly And Company S 31794/F-1 Nucleus
US4876241A (en) 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants
DK173802B1 (da) 1988-09-12 2001-11-05 Merck & Co Inc Præparat til behandling af Pneumocystis carinii infeksioner og anvendelse af et cyclohexapeptid til fremstilling af et lægemiddel mod Pneumocystis carinii infektioner
US5166135A (en) 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
CA2037957A1 (en) 1990-03-12 1991-09-13 Merck & Co., Inc. N-acylated cyclohexapeptide compounds
US5310726A (en) 1990-03-19 1994-05-10 Merck & Co., Inc. Lipopeptide compounds
EP0460882B1 (en) 1990-06-07 1996-07-24 Eli Lilly And Company Lipopeptide deacylase
FI912873L (fi) 1990-06-18 1991-12-19 Fujisawa Pharmaceutical Co Ny polypeptidfoerening och foerfarande foer dess framstaellning.
US5198421A (en) 1991-04-26 1993-03-30 Merck & Co., Inc. Phosphorylated cyclic lipopeptide
IL105048A (en) 1992-03-19 2001-06-14 Eli Lilly And Company U S Cyclic peptide antifungal agents and process for preparation thereof
US5965525A (en) 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
US5541160A (en) 1994-04-04 1996-07-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5646111A (en) 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5652213A (en) 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5618787A (en) 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5786325A (en) 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5629290A (en) 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
US5629289A (en) 1995-07-25 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
JP2001503015A (ja) * 1996-02-01 2001-03-06 イーライ・リリー・アンド・カンパニー 環状ペプチド抗真菌剤
JPH1036284A (ja) * 1996-07-24 1998-02-10 Sumitomo Pharmaceut Co Ltd プロテアソーム阻害剤
AU8687798A (en) 1997-08-04 1999-02-22 Eli Lilly And Company Cyclic peptide antifungal agents
US6232290B1 (en) * 1998-02-09 2001-05-15 Fujisawa Pharmaceutical Co., Ltd. Cyclic hexapeptides with antimicrobial activity
US6323176B1 (en) 1998-02-25 2001-11-27 Eli Lilly And Company Cyclic peptide antifungal agents
EP1107981B1 (en) 1998-08-20 2005-01-26 Eli Lilly & Company Synthesis of ring-modified cyclic peptide analogs
ATE267210T1 (de) 1998-08-28 2004-06-15 Lilly Co Eli Reversible borkomplexe von 1,2-(cis)-diol zyklischen peptiden
CN1337968A (zh) 1998-12-09 2002-02-27 伊莱利利公司 蓝刺菌素环肽化合物的纯化
JP2002535248A (ja) 1998-12-16 2002-10-22 イーライ リリー アンド カンパニー 環式ペプチド抗真菌剤
CA2354055A1 (en) 1998-12-16 2000-06-22 Eli Lilly And Company Cyclic peptide antifungal agents having a sugar substituent
DK1155034T3 (da) 1999-03-03 2007-01-08 Lilly Co Eli Dannelse og anionbytning af indre krystallinske echinocandin B-ammoniumsalte
KR20020003864A (ko) 1999-03-03 2002-01-15 피터 지. 스트링거 에키노칸딘/탄수화물 착물
JP2002538097A (ja) 1999-03-03 2002-11-12 イーライ リリー アンド カンパニー 薬学的経口ecb処方物および組成物の作製方法
CN100335122C (zh) 1999-03-03 2007-09-05 伊莱利利公司 含有成胶束表面活性剂的棘白菌素药物制剂

Also Published As

Publication number Publication date
HK1040087A1 (zh) 2002-05-24
KR20020002476A (ko) 2002-01-09
DE60030415T2 (de) 2007-08-30
CA2362826A1 (en) 2000-09-08
US20020161176A1 (en) 2002-10-31
DK1155034T3 (da) 2007-01-08
CN1351610A (zh) 2002-05-29
JP4063497B2 (ja) 2008-03-19
WO2000052036A1 (en) 2000-09-08
BR0009248A (pt) 2001-11-20
JP2002538165A (ja) 2002-11-12
ES2270819T3 (es) 2007-04-16
ZA200107999B (en) 2003-06-25
ATE338060T1 (de) 2006-09-15
US6590073B2 (en) 2003-07-08
AU3718200A (en) 2000-09-21
EP1155034A1 (en) 2001-11-21
AU767956B2 (en) 2003-11-27
DE60030415D1 (de) 2006-10-12
IL145186A0 (en) 2002-06-30
EP1155034B1 (en) 2006-08-30
WO2000052036A8 (en) 2001-06-21
PT1155034E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
CY1105777T1 (el) Σχηματισμος και ανιοντο-ανταλλαγη των εσωτepικων κρυσταλλικων αλατων αμμωνιου εχινοκανδινης β
ES8706165A1 (es) Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida.
YU39292A (sh) Nove nehigroskopne mono-amonium soli
MX9303441A (es) Procedimiento para la preparacion de acido clavulanico.
HUP9903454A2 (hu) Cefditoren-pivoxil kristályos formája, és eljárás annak előállítására
ATE149509T1 (de) Verfahren zur herstellung von 2-chlor-2'- desoxyadenosin
HUP9800615A2 (hu) Eljárás bisz(hidroxi-metil)-vegyületek előállítására
CY1110539T1 (el) Μεθοδος για παραγωγα φαινυλοξικου οξεος
BR0002297A (pt) Aditivo de gênero alimentìcio que contém ácido d-pantotênico e/ou seus sais e um processo para a sua preparação
UA41904C2 (uk) Спосіб одержання бензопіранових сполук, проміжні сполуки, спосіб одержання проміжних сполук
EA200100514A1 (ru) Способ получения метионина
AU8728801A (en) Method and agents on the basis of 2-mercaptopropionic acid amides for durable hair forming and a method for producing same
BR9102466A (pt) Processo para a preparacao de um composto quimico e composto de piridina-dicarboxilato
MX2024010008A (es) Formas polimorficas y metodos de produccion de formas polimorficas de un compuesto.
AR126196A1 (es) Proceso para preparar inhibidores de egfr
DE3867899D1 (de) Verfahren zur herstellung von 4-amino-androstendion-derivaten.
ATE267799T1 (de) Ein verfahren zur herstellung von (2s,2'r,3'r)-2- (2,3-dicarboxycyclopropyl)-glycin
PL362392A1 (pl) Sposób wytwarzania pochodnych taksanu
BR9913989A (pt) Derivados de 6-(4-fenilbutóxi)hexilamina e processo para a obtenção de salmeterol
DE69521887D1 (de) Verbessertes verfahren zur herstellung von 6,9[(zaminoethyl)amino]benzo[g]isochinoline-5,10 dione und sein dimaleinsaeure salz
EA199900765A1 (ru) Новые производные эритромицина, способ их получения и их применение в качестве лекарственных средств
NO994083L (no) Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser
ATE284837T1 (de) Verfahren zur herstellung einer salzfreien, waessrigen hydroxylaminloesung
BRPI0417300A (pt) métodos para a preparação de compostos de tiazolpirimidina
ES541215A0 (es) Un metodo para preparar un cianoimidazol-nucleosido